Social And Administrative Pharmacy

Social and administrative pharmacy is the part of pharmacy that studies medicines as social and economic objects, not only as chemical ones.

13 frameworks, from 1945 to today · Pharmacy · Medicine & Health

still a working view ended · each leads to its entry below

Overview

Social and administrative pharmacy is the part of pharmacy that studies medicines as social and economic objects, not only as chemical ones. Where pharmaceutics asks how to make a drug into a usable product and pharmacology asks what it does inside the body, this field asks a different set of questions: Who can afford this medicine? Who decides what gets approved, priced, reimbursed, and prescribed? Why do patients take some medicines and not others? What does a drug cost a health system relative to what it delivers? How do errors happen, and how can they be prevented? Its practitioners are pharmacists, economists, epidemiologists, policy analysts, and health-services researchers. What is at stake is the gap between a medicine that exists and a medicine that actually reaches people, gets taken correctly, and does more good than harm.

The field's name signals its two prongs. The social side borrows from sociology, anthropology, and psychology to study how people and institutions use medicines. The administrative side borrows from economics, management, and law to study how health systems organize, pay for, and regulate them. The two grew up alongside each other and now overlap heavily.

From Apothecary Economics to Health-System Pharmacy

For most of pharmacy's history, the administrative dimension was invisible because it was simply part of the trade. Apothecaries priced their own compounds, competed with physicians who also dispensed, and operated under guild and, later, state regulation. The great pharmacopoeias—the London and Edinburgh pharmacopoeias and their successors—were administrative instruments as much as scientific ones: they standardized what a named preparation should contain, which made prices and expectations comparable.

The turning point was the industrial manufacture of standardized medicines in the late nineteenth and early twentieth centuries, which split compounding from dispensing and pushed the pharmacist's economic role toward retail margin and dispensing fee. Two world wars accelerated state involvement: drug shortages and military procurement forced governments to think about supply, quality, and price. The U.S. Federal Food, Drug, and Cosmetic Act of 1938, which required pre-market proof of safety, and the 1962 thalidomide-driven amendments, which added proof of efficacy, established the modern regulatory apparatus that administrative pharmacy would later study. In the United Kingdom, the establishment of the National Health Service in 1948 made pharmaceutical expenditure a public budget line, and pharmacy contractors negotiated national remuneration—an early, concrete case of pharmaceutical policy analysis in practice.

Hospital pharmacy administration developed as its own discipline in the mid-twentieth century, with formularies, purchasing committees, and pharmacy and therapeutics committees becoming standard. The U.S. hospital pharmacist Donald Francke and the journal he founded, Drug Intelligence (later Drug Intelligence and Clinical Pharmacy), helped articulate hospital pharmacy as a managed system rather than a dispensing counter.

Social Pharmacy and the Behavioural Turn

From the 1960s, a distinctly social strand emerged, initially in the Nordic countries and the United Kingdom. Researchers began applying sociological methods to medicines: studies of prescribing variation, of patient medicine use in the home, and of the pharmacist's professional role. The term social pharmacy crystallized in Nordic and British academic departments in the 1970s and 1980s. The insight that drove it was that prescribing and use are social behaviours—shaped by habits, beliefs, family, advertising, and professional norms—and cannot be understood from the drug's pharmacology alone.

A concrete landmark in this tradition was the study of how patients actually take medicines in their own homes, which repeatedly found that prescribed regimens were adapted, shared, and abandoned in ways no clinical trial captured. This observational strand fed directly into the next major idea.

Pharmaceutical Care and the Reprofessionalization of Pharmacy

In 1990, the American pharmacists Charles Hepler and Linda Strand published a paper arguing that pharmacy's true social mandate was not dispensing products but taking responsibility for the outcomes of drug therapy—a concept they called pharmaceutical care12. A pharmaceutical care practitioner identifies a patient's drug-related needs, prevents and resolves drug therapy problems, and is accountable for results. The idea spread globally and was taken up by the International Pharmaceutical Federation. It reframed the profession's claim on public trust: pharmacists would justify their role by outcomes, not by the act of dispensing. It also created a research agenda—how to measure drug-related problems, how to document pharmacist interventions, how to show that pharmaceutical care improves outcomes—that administrative and social pharmacy methods were needed to answer.

Measuring Medicines: Pharmacoeconomics and Outcomes Research

The 1970s and 1980s brought cost-consciousness to health care, and pharmacy responded by importing economic methods. The question pharmacoeconomics asks is simple to state and hard to answer: given limited money, is this medicine worth what it costs compared with the alternatives? Its core tools are cost-effectiveness analysis (cost per unit of health gained, often per quality-adjusted life-year, a combined measure of length and quality of life), cost-utility analysis, cost-benefit analysis, and budget-impact analysis. The quality-adjusted life-year, or QALY, developed by health economists in the 1970s, became the standard yardstick3.

Pharmacy's contribution was to apply these tools at the level of the drug and the drug class, and to build the data infrastructure they require. The journal PharmacoEconomics, founded in 1992, marked the field's consolidation. Closely related was the rise of outcomes research—studies of what actually happens to patients under real-world conditions, as opposed to the controlled conditions of trials.

Pharmacoepidemiology: Medicines in Populations

Pharmacoepidemiology applies epidemiological methods to drug use in whole populations4. Its founding problem was that pre-marketing trials are too small and too short to detect rare harms or harms that emerge in the old, the young, and the multiply ill. The field's methods—cohort studies, case-control studies, and later the case-crossover and self-controlled designs—were developed to detect signals from routine data. The field was named and given textbook form by Brian Strom in the 1980s. It supplied the evidence base for large withdrawals of drugs found to cause unexpected harm and for the routine systems of adverse-drug-reaction reporting that regulators now maintain.

Medication Adherence: From Compliance to Concordance

Medication adherence research began in earnest in the 1970s, when clinicians noticed that a large share of prescriptions were never filled or not taken as directed. Early work used the language of compliance, framing non-taking as patient failure. A shift occurred in the 1990s toward adherence and then toward concordance—the idea that the prescribing encounter should be a negotiation, with the patient's beliefs and priorities taken seriously. Researchers such as Robert Horne and John Weinman developed instruments to measure patients' beliefs about medicines, showing that concerns about harm and perceived necessity predicted taking behaviour better than demographic factors. The field produced a large catalogue of adherence measures—pill counts, pharmacy refill records, electronic monitoring, self-report—each with known biases, and a sobering conclusion: most adherence interventions produce modest effects.

Medication Safety and Deprescribing

The 1990s turned patient safety into a discipline after studies of hospital harm, and pharmacy developed its own strand. Medication safety research catalogues error types, studies prescribing cascades (where a drug's side effect is treated with another drug), and designs interventions at the system level. The related concept of deprescribing—the planned, supervised withdrawal of medicines that no longer do more good than harm—emerged in geriatric and palliative care in the 2000s, with explicit frameworks and tools for tapering. It is the logical endpoint of the outcomes focus: if a medicine's risks outweigh its benefits, the right clinical act may be to stop it.

Access to Medicines and Pharmaceutical Policy

From the late 1990s, globalization and the HIV/AIDS crisis put access at the centre of the field. The question—why do effective medicines remain out of reach for much of the world?—drove research on pricing, patents, voluntary licensing, tiered pricing, and the TRIPS agreement's flexibilities. The concept of essential medicines, developed by the World Health Organization from 1977, provided a policy instrument: a list of medicines judged necessary for basic health care, used by many countries to guide procurement. Policy analysis in this vein studies regulation, reimbursement, intellectual property, and procurement as levers on access and affordability.

Health Technology Assessment and Evidence-Based Reimbursement

Health technology assessment, or HTA, is the systematic evaluation of a health technology's clinical, economic, and social consequences, used to inform coverage decisions5. Its institutional rise from the 1980s—through bodies such as the U.S. Office of Technology Assessment, and later agencies in Canada, the UK (NICE, established 1999), and across Europe—gave pharmacoeconomics and pharmacoepidemiology a direct route into policy. HTA synthesizes systematic reviews, economic models, and budget impact into a recommendation. It is where the field's measurement tools meet the state's purchasing power, and it has made the field's methods matter to patients far beyond academia.

The Present Field

Today social and administrative pharmacy is a mature, methodologically diverse field taught in pharmacy schools worldwide and published across journals of pharmacy practice, health economics, pharmacoepidemiology, and health policy. Its main approaches descend clearly from the history above: pharmacoepidemiological data analysis from population medicine and drug safety; pharmacoeconomic and HTA modelling from health economics; social-pharmacy qualitative and survey methods from sociology and psychology; and policy analysis of pricing, regulation, and access from law and political economy. The unifying question remains the one that gave the field its identity—how do medicines become, or fail to become, effective care?

Several questions remain open. How should value be priced when expensive new therapies, from gene therapies to oncology drugs, strain budgets and HTA methods built around the QALY? How can real-world data from electronic records and registries be made reliable enough to substitute for or supplement trials? How should deprescribing and medication safety be built into routine care rather than added on? And how can access be widened globally without undermining the innovation that produces new medicines? These are the live edges of a field that began by noticing that a drug on a shelf is not yet a medicine in a person.

References

  1. Pharmacy (Consultant pharmacy), Wikipedia
  2. Pharmaceutical care (History), Wikipedia
  3. Quality-adjusted life year (History), Wikipedia
  4. Pharmacoepidemiology, Wikipedia
  5. Health technology assessment, Wikipedia

The frameworks of Social And Administrative Pharmacy

Each framework is a way of working the field has used: when it held, and the question it answers.

  1. 1945-Present

    Hospital Pharmacy Administration

    How should a hospital pharmacy be organized and managed?

    Fly to its tower in Nousfarer

  2. 1950-Present

    Pharmacy Administration

    How should medicines be managed and paid for?

    Fly to its tower in Nousfarer

  3. 1970-Present

    Patient adherence

    Why do patients not take medicines as prescribed?

    Fly to its tower in Nousfarer

  4. 1970-Present

    Social Pharmacy

    How do people and institutions use medicines?

    Fly to its tower in Nousfarer

  5. 1977-Present

    Pharmaceutical policy

    Who decides what medicines are approved and paid for?

    Fly to its tower in Nousfarer

  6. 1980-Present

    Pharmacoeconomics

    Is a medicine worth what it costs?

    Fly to its tower in Nousfarer

  7. 1980-Present

    Pharmacoepidemiology

    What happens when medicines are used by whole populations?

    Fly to its tower in Nousfarer

  8. 1985-Present

    Health Technology Assessment

    Should a health technology be adopted and paid for?

    Fly to its tower in Nousfarer

  9. 1985-Present
  10. 1990-Present

    Medication Safety

    How do medication errors happen and how can they be prevented?

    Fly to its tower in Nousfarer

  11. 1990-Present

    Pharmaceutical Care

    How can pharmacists take responsibility for drug therapy outcomes?

    Fly to its tower in Nousfarer

  12. 1995-Present

    Access to Medicines

    Why do effective medicines remain out of reach for many people?

    Fly to its tower in Nousfarer

  13. 2005-Present

How the ideas connect

Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.

Hospital Pharmacy AdministrationPharmacy AdministrationPatient adherenceSocial PharmacyPharmaceutical policyPharmacoeconomicsPharmacoepidemiologyHealth Technology AssessmentOutcomes ResearchMedication SafetyPharmaceutical CareAccess to MedicinesDeprescribing

Beyond the field

Where Social And Administrative Pharmacy's ideas came from in other fields, and what they led to there: the strongest 12 of 63 links.

A city in Nousfarer: a red-carpeted stair climbing terraces to a crowned tower on an acropolis, more towers round it, forest and snowy mountains beyond.
A city in Nousfarer, the game played in the browser.

Social And Administrative Pharmacy is a planet in Nousfarer

Its city has a tower for each of these 13 frameworks. Land, walk in, and climb one concept at a time.

Land on Social And Administrative Pharmacy

Related fields

Fields its ideas are linked to

More in Pharmacy

See where Social And Administrative Pharmacy sits on the Map of Human Knowledge